MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gim.2021.12.012

Медицинская библиотека · Genetics in medicine : official journal of the American College of Medical Genetics · 2022

TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.

Radenkovic Silvia, Martinelli Diego, Zhang Yuebo, Preston Graeme J, Maiorana Arianna, Terracciano Alessandra, Dentici Maria Lisa, Pisaneschi Elisa, Novelli Antonio, Ranatunga Wasantha, Ligezka Anna N, Ghesquière Bart, Deyle David R, Kozicz Tamas, Pinto E Vairo Filippo, Witters Peter, Morava Eva

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: TRAPPC9 deficiency is an autosomal recessive disorder mainly associated with intellectual disability (ID), microcephaly, and obesity. Previously, TRAPPC9 deficiency has not been associated with biochemical abnormalities.

METHODS

Exome sequencing was performed in 3 individuals with ID and dysmorphic features. N-Glycosylation analyses were performed in the patients' blood samples to test for possible congenital disorder of glycosylation (CDG). TRAPPC9 gene, TRAPPC9 protein expression, and N-glycosylation markers were assessed in patient fibroblasts. Complementation with wild-type TRAPPC9 and immunofluorescence studies to assess TRAPPC9 expression and localization were performed. The metabolic consequences of TRAPPC9 deficiency were evaluated using tracer metabolomics.

RESULTS

All 3 patients carried biallelic missense variants in TRAPPC9 and presented with an N-glycosylation defect in blood, consistent with CDG type I. Extensive investigations in patient fibroblasts corroborated TRAPPC9 deficiency and an N-glycosylation defect. Tracer metabolomics revealed global metabolic changes with several affected glycosylation-related metabolites.

CONCLUSION

We identified 3 TRAPPC9 deficient patients presenting with ID, dysmorphic features, and abnormal glycosylation. On the basis of our findings, we propose that TRAPPC9 deficiency could lead to a CDG (TRAPPC9-CDG). The finding of abnormal glycosylation in these patients is highly relevant for diagnosis, further elucidation of the pathophysiology, and management of the disease.

Для цитирования: Radenkovic Silvia, Martinelli Diego, Zhang Yuebo, Preston Graeme J, Maiorana Arianna, Terracciano Alessandra, Dentici Maria Lisa, Pisaneschi Elisa, Novelli Antonio, Ranatunga Wasantha, Ligezka Anna N, Ghesquière Bart, Deyle David R, Kozicz Tamas, Pinto E Vairo Filippo, Witters Peter, Morava Eva. TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability.. Genetics in medicine : official journal of the American College of Medical Genetics. 2022. DOI: 10.1016/j.gim.2021.12.012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.